Topic

New York

A collection of 516 issues

Myths vs. Facts: Getting Uptravi (Selexipag) Covered by Blue Cross Blue Shield in New York

Answer Box: Getting Uptravi Covered by Blue Cross Blue Shield in New York Uptravi (selexipag) requires prior authorization from Blue Cross Blue Shield plans in New York for pulmonary arterial hypertension (PAH). Success depends on documenting WHO Group I PAH via right heart catheterization, failed trials of background therapies, and

How to Get Darzalex Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Darzalex Approved by Blue Cross Blue Shield in New York Darzalex requires prior authorization from all Blue Cross Blue Shield plans in New York. Submit your PA request using plan-specific forms with complete documentation: multiple myeloma diagnosis (ICD-10 C90.0), prior therapy failures, and medical necessity justification.

How to Get Exondys 51 (Eteplirsen) Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Exondys 51 Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Exondys 51 (eteplirsen) with specific criteria: confirmed DMD with exon 51-amenable mutation, ambulatory status, specialist prescriber, and baseline testing. First step: Contact a DMD specialist at Mount Sinai or NYU Langone to order genetic

Myths vs. Facts: Getting Voydeya (danicopan) Covered by Aetna (CVS Health) in New York

Answer Box: Getting Voydeya (danicopan) Covered by Aetna (CVS Health) in New York Voydeya (danicopan) requires prior authorization from Aetna CVS Health for PNH patients with extravascular hemolysis. Key requirements include confirmed PNH diagnosis by flow cytometry, current C5 inhibitor therapy, documented EVH evidence (labs showing persistent anemia/hemolysis), REMS

How to Get Xospata (Gilteritinib) Covered by UnitedHealthcare in New York: Forms, Appeals, and Provider Contacts

Answer Box: Getting Xospata Covered by UnitedHealthcare in New York Xospata (gilteritinib) requires prior authorization from UnitedHealthcare for relapsed/refractory FLT3-mutated AML. Key steps: (1) Submit PA via UnitedHealthcare Provider Portal with FLT3 mutation test and prior therapy records, (2) If denied, file internal appeal within 180 days, (3) Request

How to Get Revlimid (lenalidomide) Covered by Aetna (CVS Health) in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Approval To get Revlimid (lenalidomide) covered by Aetna (CVS Health) in New York: First, ensure your prescriber and pharmacy are enrolled in the mandatory Lenalidomide REMS program. Submit prior authorization through Aetna's provider portal with diagnosis codes, prior therapy documentation, and REMS certification

Renewing Tepezza (Teprotumumab) Approval with Aetna CVS Health in New York: Complete Guide to Documentation and Timelines

Answer Box: Renewing Tepezza Coverage Most Aetna CVS Health plans limit Tepezza to one 8-infusion course per lifetime. Renewal beyond 8 doses requires exceptional documentation showing unmet clinical need plus peer-reviewed evidence supporting extended treatment. Start renewal requests 2-4 weeks before your final scheduled infusion. If denied, New York residents

How to Get Rebif (Interferon Beta-1a) Covered by Humana in New York: Complete Guide with Forms and Appeal Scripts

Answer Box: Getting Rebif Covered by Humana in New York Most Humana plans require prior authorization for Rebif (interferon beta-1a). Submit via Humana's Medicare Prescription Drug Coverage Determination form (fax: 877-486-2621) or provider portal. Include MS diagnosis, prior DMT failures, MRI/relapse history, and medical necessity letter. Standard

How to Get Retevmo (Selpercatinib) Covered by Humana in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Retevmo Covered by Humana in New York Retevmo (selpercatinib) requires prior authorization under Humana Medicare plans and may be non-formulary depending on your specific plan. To get coverage in New York: 1) Have your oncologist submit a prior authorization request with RET mutation testing results and medical

How to Get Zokinvy (lonafarnib) Covered by UnitedHealthcare in New York: Complete Appeal Guide

Quick Answer: Getting Zokinvy Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Zokinvy (lonafarnib) with specific genetic testing requirements. For HGPS patients, you need confirmed diagnosis only. For progeroid laminopathies, you must document heterozygous LMNA mutation with progerin-like protein accumulation OR homozygous/compound heterozygous ZMPSTE24 mutations. Submit